SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-020976
Filing Date
2021-05-27
Accepted
2021-05-27 20:32:46
Documents
2
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3410
2 EX-24 DOCUMENT attachment1.htm EX-24 4785
  Complete submission text file 0000899243-21-020976.txt   9798
Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC D. HODGKIN BLDG, BABRAHAM RSRCH CAMPUS CAMBRIDGE X0 CB22 3FH
Business Address
SAHA SAURABH (Reporting) CIK: 0001861926 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40445 | Film No.: 21975364